98 related articles for article (PubMed ID: 15014711)
1. Escitalopram: A New SSRI for the Treatment of Depression in Primary Care.
Culpepper L
Prim Care Companion J Clin Psychiatry; 2002 Dec; 4(6):209-214. PubMed ID: 15014711
[TBL] [Abstract][Full Text] [Related]
2. Escitalopram: a second-generation SSRI.
Owens MJ; Rosenbaum JF
CNS Spectr; 2002 Apr; 7(4 Suppl 1):34-9. PubMed ID: 15131491
[TBL] [Abstract][Full Text] [Related]
3. Escitalopram for the treatment of major depression and anxiety disorders.
Höschl C; Svestka J
Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657
[TBL] [Abstract][Full Text] [Related]
4. Escitalopram: a unique mechanism of action.
Bræstrup C; Sanchez C
Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():11-3. PubMed ID: 24930683
[TBL] [Abstract][Full Text] [Related]
5. Escitalopram: a pharmacoeconomic review of its use in depression.
Croom KF; Plosker GL
Pharmacoeconomics; 2003; 21(16):1185-209. PubMed ID: 14594439
[TBL] [Abstract][Full Text] [Related]
6. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials.
Gorman JM; Korotzer A; Su G
CNS Spectr; 2002 Apr; 7(4 Suppl 1):40-4. PubMed ID: 15131492
[TBL] [Abstract][Full Text] [Related]
7. Comparison of escitalopram and citalopram efficacy: A meta-analysis.
Auquier P; Robitail S; Llorca PM; Rive B
Int J Psychiatry Clin Pract; 2003; 7(4):259-68. PubMed ID: 24930412
[TBL] [Abstract][Full Text] [Related]
8. Escitalopram: a review of its use in the management of major depressive disorder.
Murdoch D; Keam SJ
Drugs; 2005; 65(16):2379-404. PubMed ID: 16266205
[TBL] [Abstract][Full Text] [Related]
9. An emerging role for escitalopram in the treatment of obsessive-compulsive disorder.
Hedges DW; Woon FL
Neuropsychiatr Dis Treat; 2007 Aug; 3(4):455-61. PubMed ID: 19300574
[TBL] [Abstract][Full Text] [Related]
10. The importance of serotonin and noradrenaline in anxiety.
Blier P; El Mansari M
Int J Psychiatry Clin Pract; 2007; 11 Suppl 2():16-23. PubMed ID: 24926868
[TBL] [Abstract][Full Text] [Related]
11. Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration.
Dong C; Zhang JC; Yao W; Ren Q; Yang C; Ma M; Han M; Saito R; Hashimoto K
Pharmacol Biochem Behav; 2016 May; 144():7-12. PubMed ID: 26892759
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram: a review of its use in the management of anxiety disorders.
Dhillon S; Scott LJ; Plosker GL
CNS Drugs; 2006; 20(9):763-90. PubMed ID: 16953656
[TBL] [Abstract][Full Text] [Related]
13. [Severe forms of depression: the efficacy of escitalopram].
Spadone C
Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
[TBL] [Abstract][Full Text] [Related]
14. Priorities in treating depression only.
Lam RW
Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():25-9. PubMed ID: 24930686
[TBL] [Abstract][Full Text] [Related]
15. [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].
Owens JM; Knight DL; Nemeroff CB
Encephale; 2002; 28(4):350-5. PubMed ID: 12232544
[TBL] [Abstract][Full Text] [Related]
16. The antidepressant- and anxiolytic-like effects following co-treatment with escitalopram and risperidone in rats.
Kaminska K; Rogoz Z
J Physiol Pharmacol; 2016 Jun; 67(3):471-80. PubMed ID: 27512008
[TBL] [Abstract][Full Text] [Related]
17. Escitalopram in the treatment of generalized anxiety disorder.
Baldwin DS; Nair RV
Expert Rev Neurother; 2005 Jul; 5(4):443-9. PubMed ID: 16026227
[TBL] [Abstract][Full Text] [Related]
18. [Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram, in patients with major depressive disorder--the navigade switch study].
Schmitt L; Arbus C; Tonnoir B
Encephale; 2006; 32(2 Pt 1):270-7. PubMed ID: 16910629
[TBL] [Abstract][Full Text] [Related]
19. New treatment options for OCD.
Fineberg NA
Int J Psychiatry Clin Pract; 2007; 11 Suppl 2():24-30. PubMed ID: 24926869
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT
Park YS; Sung KW
Korean J Physiol Pharmacol; 2019 Nov; 23(6):509-517. PubMed ID: 31680773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
